SRTA
Strata Critical Medical, Inc.
NASDAQ: SRTA · HEALTHCARE · MEDICAL CARE FACILITIES
$5.47
-7.51% today
Updated 2026-06-05
Market cap
$458.59M
P/E ratio
—
P/S ratio
2.01x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$4 – $7
Volume
1.1M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
7.3
Growth
B+8.5
Quality
A5.0
Profitability
C+5.0
Valuation
C+2/9
Piotroski F-Score
Weak
3.8
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →205 stocks currently score above 75
Price targets
Analyst target
$9.25
+69.10%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.78 — safe zone
+ Profit margin 20.60% — above average
+ Revenue growth 87.40% QoQ
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Negative free cash flow $-1.93M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $146.12M | $225.18M | $248.69M | $197.14M | $228.58M |
| Net income | $-27.26M | $-56.08M | $-27.31M | $-15.65M | $2.50M |
| EPS | — | — | — | — | $-0.19 |
| Free cash flow | $-37.86M | $-34.46M | $-35.51M | $-59.92M | $-1.93M |
| Profit margin | -18.66% | -24.90% | -10.98% | -7.94% | 20.60% |
Peer comparison
Smart narrative
Strata Critical Medical, Inc. trades at $5.47. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 3.78, it sits in the safe zone. TTM revenue stands at $228.58M. with profit margins at 20.60%.
Frequently asked questions
What is Strata Critical Medical, Inc.'s stock price?
Strata Critical Medical, Inc. (SRTA) trades at $5.47, on a P/S of 2.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Strata Critical Medical, Inc. overvalued?
Strata Critical Medical, Inc. carries a Smart Value Score of 51/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Strata Critical Medical, Inc. (SRTA)?
The 12-month analyst consensus target is $9.25, about 69.1% above the current $5.47. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Strata Critical Medical, Inc.'s revenue?
Strata Critical Medical, Inc.'s trailing twelve-month revenue is $228.58M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Strata Critical Medical, Inc.'s Altman Z-Score is 3.78, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.01x
ROE17.77%
Beta2.20
50D MA$5.48
200D MA$4.97
Shares out0.09B
Float0.06B
Short ratio—
Avg volume1.1M
Performance
1 week-8.84%
1 month-15.06%
3 months+29.47%
YTD+11.43%
1 year—
3 years—
5 years—